Gene · 6295
SAG: S-antigen visual arrestin
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SAG: S-antigen visual arrestin. Genes, record 6295. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6295
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P10523 | S-arrestin | 405 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents89
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026515744 A | 2026-05-19 | 71 | P10523 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 62617 | P10523 | Espacenet |
| EP 4670794 A2 | 2025-12-31 | 41 | P10523 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 1941 | P10523 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 12944 | P10523 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 1941 | P10523 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 12944 | P10523 | Espacenet |
| US 12275959 B2 | 2025-04-15 | 21 | P10523 | Espacenet |
| JP 2025508740 A | 2025-04-10 | 151 | P10523 | Espacenet |
| US 12246072 B2 | 2025-03-11 | 35 | P10523 | Espacenet |
1 to 10 of 89
See all 89 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,136
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SAG papers | Newest fiscal year |
|---|---|---|---|
| R01EY011500 | Structure-function studies of visual arrestin | 65 | 2025 |
| P30EY008126 | Core Grant in Vision Research | 9 | 2025 |
| R01HL016037 | Molecular Regulation of Cardiovascular 7 TM Receptors | 8 | 2025 |
| P30EY001730 | Vision Research Core | 7 | 2025 |
| R01EY018213 | Defining Barriers to Gene Therapy | 7 | 2025 |
| ZIAEY000184 | Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina | 7 | 2025 |
| P30EY000331 | Vision Research Core at UCLA | 6 | 2025 |
| R01GM120569 | Molecular basis for arrestin-mediated signaling | 6 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 4 | 2025 |
| R01EY012155 | Phototransduction in health and disease | 4 | 2025 |
1 to 10 of 1,136Source NIH's project files
See all 1,136 nih grantsPapers1,541
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A uniquely human sebum lipid drives streptococcal skin infection severity. | mBio | 2026 | 42690049 | PubTator, text mining | PubMed |
| Multi-Omics Framework Integrating Genetics, Microbiome, Metabolism, and Immunity for Deciphering Ulcerative Colitis Pathogenesis and Diagnostic Biomarker Discovery. | FASEB J | 2026 | 42411190 | PubTator, text mining | PubMed |
| Visual arrestin-1: how did we learn what we know today about this protein? | Prog Retin Eye Res | 2026 | 42398767 | PubTator, text mining | PubMed |
| Rapid and Robust Generation of Human Cortical Interneurons from Induced Neural Stem Cells. | Int J Mol Sci | 2026 | 42352918 | PubTator, text mining | PubMed |
| Expanding the Genetic Landscape of Congenital Stationary Night Blindness Through the Analysis of Consanguineous Pakistani Families. | Genes (Basel) | 2026 | 42194996 | PubTator, text mining | PubMed |
| Glycosylation-driven necroptosis in retinal degeneration: dual rescue by AAV8 gene therapy and RIPK1 inhibition. | Cell Death Discov | 2026 | 41957343 | PubTator, text mining | PubMed |
| Association between craniosynostosis and phospholipid metabolism: Insights from single-cell and transcriptomic analysis. | Medicine (Baltimore) | 2026 | 41894269 | PubTator, text mining | PubMed |
| The Immunopathogenesis of uveitis. | Front Med (Lausanne) | 2026 | 41877771 | PubTator, text mining | PubMed |
| Aortic Arch Mural Thrombus Concurrent with Deep Surgical-Site Infection after Colorectal Cancer Surgery in an Enhanced Recovery after Surgery Program: A Case Report. | Surg Case Rep | 2026 | 41783331 | PubTator, text mining | PubMed |
| Single cell and multi-omics analysis reveal senescence-related molecular subtypes and a prognostic signature in clear cell renal cell carcinoma. | Discov Oncol | 2026 | 41770477 | PubTator, text mining | PubMed |
1 to 10 of 1,541
See all 1,541 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6295
GET https://conductscience.org/api/genes/v1/6295/patents?page=2